Lip, Gregory Y.H.

Association between sodium–glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials

Sfairopoulos, D., Zhang, N., Wang, Y., Chen, Z., Letsas, K. P., Tse, G., Li, G., Lip, G. Y. H., Liu, T., & Korantzopoulos, P. (2022) · EP Europace

Diabetes Treatment and ManagementCardiac electrophysiology and arrhythmias

Cited by 76

Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database

Eleftheriadou, A., Riley, D., Zhao, S. S., Austin, P., Hernández, G., Lip, G. Y. H., Jackson, T. L., Wilding, J. P. H., & Alam, U. (2024) · Diabetologia

Diabetes Treatment and ManagementRetinal Diseases and Treatments

Cited by 73

Atrial flutter and thromboembolic risk: a systematic review

Vadmann, H., Nielsen, P. B., Hjortshøj, S. P., Riahi, S., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2015) · Heart

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 72

Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: The Belgrade atrial fibrillation study

Potpara, T. S., Marinkovic, J. M., Polovina, M. M., Stankovic, G. R., Seferovic, P. M., Ostojic, M. C., & Lip, G. Y. H. (2012) · International Journal of Cardiology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 71

Prognostic value of CHA2DS2-VASc score in patients with ‘non-valvular atrial fibrillation’ and valvular heart disease: the Loire Valley Atrial Fibrillation Project

Philippart, R., Brunet-Bernard, A., Clementy, N., Bourguignon, T., Mirza, A., Babuty, D., Angoulvant, D., Lip, G. Y. H., & Fauchier, L. (2015) · European Heart Journal

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 68

Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial

Senoo, K., Lip, G. Y. H., Lane, D. A., Büller, H. R., & Kotecha, D. (2015) · Stroke

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 64

Interactive Remote Patient Monitoring Devices for Managing Chronic Health Conditions: Systematic Review and Meta-analysis

Leo, D. G., Buckley, B. J. R., Chowdhury, M., Harrison, S. L., Isanejad, M., Lip, G. Y. H., Wright, D. J., Lane, D. A., & the TAILOR investigators (2022) · Journal of Medical Internet Research

Telemedicine and Telehealth ImplementationMobile Health and mHealth Applications

Cited by 62

The optimal management of patients on oral anticoagulation undergoing coronary artery stenting: The 10th Anniversary Overview

Faxon, D., Airaksinen, J., Schlitt, A., Marìn, F., Bhatt, D., Lip, G., & Rubboli, A. (2014) · Thrombosis and Haemostasis

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 60

Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation

Proietti, M., Raparelli, V., Laroche, C., Dan, G.-A., Janion, M., Popescu, R., Sinagra, G., Vijgen, J., Boriani, G., Maggioni, A. P., et al. (2017) · EP Europace

Atrial Fibrillation Management and OutcomesPeripheral Artery Disease Management

Cited by 58

PCSK9 in metabolism and diseases

Ajoolabady, A., Pratico, D., Mazidi, M., Davies, I. G., Lip, G. Y. H., Seidah, N., Libby, P., Kroemer, G., & Ren, J. (2025) · Metabolism

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 49

Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study

Fangel, M. V., Nielsen, P. B., Kristensen, J. K., Larsen, T. B., Overvad, T. F., Lip, G. Y. H., & Jensen, M. B. (2019) · Circulation: Arrhythmia and Electrophysiology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 49

Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis

Bisson, A., Bodin, A., Fauchier, G., Herbert, J., Angoulvant, D., Ducluzeau, P. H., Lip, G. Y. H., & Fauchier, L. (2021) · Cardiovascular Diabetology

Atrial Fibrillation Management and OutcomesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 44

Incidence of new onset type 2 diabetes in adults living with obesity treated with tirzepatide or semaglutide: real world evidence from an international retrospective cohort study

Anson, M., Henney, A. E., Broadwell, N., Zhao, S. S., Ibarburu, G. H., Lip, G. Y. H., Wilding, J. P. H., Cuthbertson, D. J., & Alam, U. (2024) · eClinicalMedicine

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 44

European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)

Gorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace

Cardiac pacing and defibrillation studiesCardiac electrophysiology and arrhythmias

Cited by 43

Prevalence of Heart Failure and Atrial Fibrillation in Minority Ethnic Subjects: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)

Gill, P. S., Calvert, M., Davis, R., Davies, M. K., Freemantle, N., & Lip, G. Y. H. (2011) · PLoS ONE

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 43

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)

Smith, D. E., Xuereb, C. B., Pattison, H. M., Lip, G. Y., & Lane, D. A. (2010) · BMC Cardiovascular Disorders

Atrial Fibrillation Management and OutcomesPharmacy and Medical Practices

Cited by 42

What are the costs of atrial fibrillation?

Blomstrom Lundqvist, C., Lip, G. Y. H., & Kirchhof, P. (2011) · Europace

Atrial Fibrillation Management and OutcomesHealth Systems, Economic Evaluations, Quality of Life

Cited by 42

Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors

Kosiuk, J., Kornej, J., Bollmann, A., Piorkowski, C., Myrda, K., Arya, A., Sommer, P., Richter, S., Rolf, S., Husser, D., et al. (2014) · Heart Rhythm

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 36

Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery: The TIGHT K Randomized Clinical Trial

O’Brien, B., Campbell, N. G., Allen, E., Jamal, Z., Sturgess, J., Sanders, J., Opondo, C., Roberts, N., Aron, J., Maccaroni, M. R., et al. (2024) · JAMA

Atrial Fibrillation Management and OutcomesCardiac, Anesthesia and Surgical Outcomes

Cited by 36

Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis

Rysz-Górzynska, M., Gluba-Brzózka, A., Sahebkar, A., Serban, M.-C., Mikhailidis, D. P., Ursoniu, S., Toth, P. P., Bittner, V., Watts, G. F., Lip, G. Y. H., et al. (2016) · Scientific Reports

Pulmonary Hypertension Research and TreatmentsBlood Pressure and Hypertension Studies

Cited by 33

Omega‐3 polyunsaturated acids and cardiovascular disease: notable ethnic differences or unfulfilled promise?

PATEL, J. V., TRACEY, I., HUGHES, E. A., & LIP, G. Y. (2010) · Journal of Thrombosis and Haemostasis

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 32

At the heart of the matter: how mental stress and negative emotions affect atrial fibrillation

Leo, D. G., Ozdemir, H., Lane, D. A., Lip, G. Y. H., Keller, S. S., & Proietti, R. (2023) · Frontiers in Cardiovascular Medicine

Atrial Fibrillation Management and OutcomesCardiac Health and Mental Health

Cited by 31

The Impact of Associated Diabetic Retinopathy on Stroke and Severe Bleeding Risk in Diabetic Patients With Atrial Fibrillation

Lip, G. Y. H., Clementy, N., Pierre, B., Boyer, M., & Fauchier, L. (2015) · Chest

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 26

Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation

Varughese, G. I., & Lip, G. Y. H. (2005) · Journal of Human Hypertension

Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies

Cited by 25